*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| C7B8 - Other secondary neuroendocrine tumors - as a primary diagnosis code | C7B8 - Other secondary neuroendocrine tumors - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 6.9 | |
| Readmission Rate (%) | 28.17 | |
| Unplanned Readmission Rate (%) | 18.68 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 843: OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 844: OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 826: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 829: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 827: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 6,611 | ||||
| Total Hospitalizations with ICD C7B8 - Other secondary neuroendocrine tumors | 417 | ||||
| DRG Share of Total Hospitalizations | 0.02 | ||||
| % of Total ICD C7B8 - Other secondary neuroendocrine tumors in DRG | 30.06 | ||||
| Avg LOS at DRG | 7.33 | ||||
| Avg LOS with ICD C7B8 - Other secondary neuroendocrine tumors | 7.4 | ||||
| Readmission Rate at DRG | 28.26 | ||||
| Readmission Rate with ICD C7B8 - Other secondary neuroendocrine tumors | 28.95 | ||||
| Unplanned Readmission Rate at DRG | 20.47 | ||||
| Unplanned Readmission Rate with ICD C7B8 - Other secondary neuroendocrine tumors | 22.22 | ||||
| Total Medicare payments at DRG | $88,080,906 | ||||
| Total Medicare payments with ICD C7B8 - Other secondary neuroendocrine tumors | $6,078,198 | ||||
| Total Medicare payment per Day at DRG | $1,818 | ||||
| Total Medicare payment per Day with ICD C7B8 - Other secondary neuroendocrine tumors | $1,971 | ||||
| Total Medicare payment per Hospitalization at DRG | $13,323 | ||||
| Total Medicare payment per Hospitalization with ICD C7B8 - Other secondary neuroendocrine tumors | $14,576 | ||||
| Total Medicare Charges at DRG | $418,952,537 | ||||
| Total Medicare Charges with ICD C7B8 - Other secondary neuroendocrine tumors | $29,397,712 | ||||
| Avg Charges at DRG | $63,372 | ||||
| Avg Charges with ICD C7B8 - Other secondary neuroendocrine tumors | $70,498 | ||||
| Mortality Rate at DRG | 14.54 | ||||
| Mortality Rate with ICD C7B8 - Other secondary neuroendocrine tumors | 13.91 | ||||
| SNF Discharge Rate at DRG | 15.2 | ||||
| SNF Discharge Rate with ICD C7B8 - Other secondary neuroendocrine tumors | 14.15 | ||||
| Home Discharge Rate at DRG | 25.06 | ||||
| Home Discharge Rate with ICD C7B8 - Other secondary neuroendocrine tumors | 25.66 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 830: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER O.R. PROCEDURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 845: OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 828: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|
| Total Hospitalizations at DRG | 1,334 | ||
| Total Hospitalizations with ICD C7B8 - Other secondary neuroendocrine tumors | 85 | ||
| DRG Share of Total Hospitalizations | 0.0 | ||
| % of Total ICD C7B8 - Other secondary neuroendocrine tumors in DRG | 6.13 | ||
| Avg LOS at DRG | 2.92 | ||
| Avg LOS with ICD C7B8 - Other secondary neuroendocrine tumors | 2.73 | ||
| Readmission Rate at DRG | 12.56 | ||
| Readmission Rate with ICD C7B8 - Other secondary neuroendocrine tumors | 15.66 | ||
| Unplanned Readmission Rate at DRG | 7.12 | ||
| Unplanned Readmission Rate with ICD C7B8 - Other secondary neuroendocrine tumors | NA | ||
| Total Medicare payments at DRG | $11,833,763 | ||
| Total Medicare payments with ICD C7B8 - Other secondary neuroendocrine tumors | $713,312 | ||
| Total Medicare payment per Day at DRG | $3,036 | ||
| Total Medicare payment per Day with ICD C7B8 - Other secondary neuroendocrine tumors | $3,075 | ||
| Total Medicare payment per Hospitalization at DRG | $8,871 | ||
| Total Medicare payment per Hospitalization with ICD C7B8 - Other secondary neuroendocrine tumors | $8,392 | ||
| Total Medicare Charges at DRG | $70,506,659 | ||
| Total Medicare Charges with ICD C7B8 - Other secondary neuroendocrine tumors | $5,861,141 | ||
| Avg Charges at DRG | $52,854 | ||
| Avg Charges with ICD C7B8 - Other secondary neuroendocrine tumors | $68,955 | ||
| Mortality Rate at DRG | NA | ||
| Mortality Rate with ICD C7B8 - Other secondary neuroendocrine tumors | NA | ||
| SNF Discharge Rate at DRG | 3.75 | ||
| SNF Discharge Rate with ICD C7B8 - Other secondary neuroendocrine tumors | NA | ||
| Home Discharge Rate at DRG | 79.16 | ||
| Home Discharge Rate with ICD C7B8 - Other secondary neuroendocrine tumors | 89.41 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 38 |
| MOFFITT CANCER CENTER | 12902 MAGNOLIA DR | TAMPA | FL | 33612 | 36 |
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 28 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 843: OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 844: OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 827: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 829: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 6,611 | ||||
| Total Hospitalizations with ICD C7B8 - Other secondary neuroendocrine tumors | 745 | ||||
| DRG Share of Total Hospitalizations | 0.02 | ||||
| % of Total ICD C7B8 - Other secondary neuroendocrine tumors in DRG | 10.63 | ||||
| Avg LOS at DRG | 7.33 | ||||
| Avg LOS with ICD C7B8 - Other secondary neuroendocrine tumors | 8.37 | ||||
| Readmission Rate at DRG | 28.26 | ||||
| Readmission Rate with ICD C7B8 - Other secondary neuroendocrine tumors | 29.7 | ||||
| Unplanned Readmission Rate at DRG | 20.47 | ||||
| Unplanned Readmission Rate with ICD C7B8 - Other secondary neuroendocrine tumors | 21.98 | ||||
| Total Medicare payments at DRG | $88,080,906 | ||||
| Total Medicare payments with ICD C7B8 - Other secondary neuroendocrine tumors | $10,769,066 | ||||
| Total Medicare payment per Day at DRG | $1,818 | ||||
| Total Medicare payment per Day with ICD C7B8 - Other secondary neuroendocrine tumors | $1,726 | ||||
| Total Medicare payment per Hospitalization at DRG | $13,323 | ||||
| Total Medicare payment per Hospitalization with ICD C7B8 - Other secondary neuroendocrine tumors | $14,455 | ||||
| Total Medicare Charges at DRG | $418,952,537 | ||||
| Total Medicare Charges with ICD C7B8 - Other secondary neuroendocrine tumors | $57,451,356 | ||||
| Avg Charges at DRG | $63,372 | ||||
| Avg Charges with ICD C7B8 - Other secondary neuroendocrine tumors | $77,116 | ||||
| Mortality Rate at DRG | 14.54 | ||||
| Mortality Rate with ICD C7B8 - Other secondary neuroendocrine tumors | 15.03 | ||||
| SNF Discharge Rate at DRG | 15.2 | ||||
| SNF Discharge Rate with ICD C7B8 - Other secondary neuroendocrine tumors | 14.9 | ||||
| Home Discharge Rate at DRG | 25.06 | ||||
| Home Discharge Rate with ICD C7B8 - Other secondary neuroendocrine tumors | 22.68 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 826: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 828: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 845: OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 830: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER O.R. PROCEDURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 2,430 | ||||
| Total Hospitalizations with ICD C7B8 - Other secondary neuroendocrine tumors | 321 | ||||
| DRG Share of Total Hospitalizations | 0.01 | ||||
| % of Total ICD C7B8 - Other secondary neuroendocrine tumors in DRG | 4.58 | ||||
| Avg LOS at DRG | 12.98 | ||||
| Avg LOS with ICD C7B8 - Other secondary neuroendocrine tumors | 12.25 | ||||
| Readmission Rate at DRG | 30.62 | ||||
| Readmission Rate with ICD C7B8 - Other secondary neuroendocrine tumors | 32.65 | ||||
| Unplanned Readmission Rate at DRG | 15.79 | ||||
| Unplanned Readmission Rate with ICD C7B8 - Other secondary neuroendocrine tumors | 17.69 | ||||
| Total Medicare payments at DRG | $97,116,776 | ||||
| Total Medicare payments with ICD C7B8 - Other secondary neuroendocrine tumors | $12,051,254 | ||||
| Total Medicare payment per Day at DRG | $3,080 | ||||
| Total Medicare payment per Day with ICD C7B8 - Other secondary neuroendocrine tumors | $3,064 | ||||
| Total Medicare payment per Hospitalization at DRG | $39,966 | ||||
| Total Medicare payment per Hospitalization with ICD C7B8 - Other secondary neuroendocrine tumors | $37,543 | ||||
| Total Medicare Charges at DRG | $449,416,156 | ||||
| Total Medicare Charges with ICD C7B8 - Other secondary neuroendocrine tumors | $54,094,407 | ||||
| Avg Charges at DRG | $184,945 | ||||
| Avg Charges with ICD C7B8 - Other secondary neuroendocrine tumors | $168,518 | ||||
| Mortality Rate at DRG | 8.6 | ||||
| Mortality Rate with ICD C7B8 - Other secondary neuroendocrine tumors | 5.92 | ||||
| SNF Discharge Rate at DRG | 18.56 | ||||
| SNF Discharge Rate with ICD C7B8 - Other secondary neuroendocrine tumors | 18.07 | ||||
| Home Discharge Rate at DRG | 30.53 | ||||
| Home Discharge Rate with ICD C7B8 - Other secondary neuroendocrine tumors | 28.66 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 310,318 | ||||
| Total Hospitalizations with ICD C7B8 - Other secondary neuroendocrine tumors | 103 | ||||
| DRG Share of Total Hospitalizations | 0.94 | ||||
| % of Total ICD C7B8 - Other secondary neuroendocrine tumors in DRG | 1.47 | ||||
| Avg LOS at DRG | 3.19 | ||||
| Avg LOS with ICD C7B8 - Other secondary neuroendocrine tumors | 3.82 | ||||
| Readmission Rate at DRG | 20.19 | ||||
| Readmission Rate with ICD C7B8 - Other secondary neuroendocrine tumors | 30.85 | ||||
| Unplanned Readmission Rate at DRG | 13.62 | ||||
| Unplanned Readmission Rate with ICD C7B8 - Other secondary neuroendocrine tumors | 23.4 | ||||
| Total Medicare payments at DRG | $1,415,392,709 | ||||
| Total Medicare payments with ICD C7B8 - Other secondary neuroendocrine tumors | $588,532 | ||||
| Total Medicare payment per Day at DRG | $1,431 | ||||
| Total Medicare payment per Day with ICD C7B8 - Other secondary neuroendocrine tumors | $1,498 | ||||
| Total Medicare payment per Hospitalization at DRG | $4,561 | ||||
| Total Medicare payment per Hospitalization with ICD C7B8 - Other secondary neuroendocrine tumors | $5,714 | ||||
| Total Medicare Charges at DRG | $7,113,640,596 | ||||
| Total Medicare Charges with ICD C7B8 - Other secondary neuroendocrine tumors | $3,850,707 | ||||
| Avg Charges at DRG | $22,924 | ||||
| Avg Charges with ICD C7B8 - Other secondary neuroendocrine tumors | $37,386 | ||||
| Mortality Rate at DRG | 0.63 | ||||
| Mortality Rate with ICD C7B8 - Other secondary neuroendocrine tumors | NA | ||||
| SNF Discharge Rate at DRG | 19.76 | ||||
| SNF Discharge Rate with ICD C7B8 - Other secondary neuroendocrine tumors | NA | ||||
| Home Discharge Rate at DRG | 50.47 | ||||
| Home Discharge Rate with ICD C7B8 - Other secondary neuroendocrine tumors | 47.57 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 389: G.I. OBSTRUCTION WITH COMPLICATION OR COMORBIDITY (CC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 522,791 | ||||
| Total Hospitalizations with ICD C7B8 - Other secondary neuroendocrine tumors | 82 | ||||
| DRG Share of Total Hospitalizations | 1.59 | ||||
| % of Total ICD C7B8 - Other secondary neuroendocrine tumors in DRG | 1.17 | ||||
| Avg LOS at DRG | 3.14 | ||||
| Avg LOS with ICD C7B8 - Other secondary neuroendocrine tumors | 3.48 | ||||
| Readmission Rate at DRG | 17.1 | ||||
| Readmission Rate with ICD C7B8 - Other secondary neuroendocrine tumors | 32.47 | ||||
| Unplanned Readmission Rate at DRG | 12.62 | ||||
| Unplanned Readmission Rate with ICD C7B8 - Other secondary neuroendocrine tumors | 24.68 | ||||
| Total Medicare payments at DRG | $2,290,151,156 | ||||
| Total Medicare payments with ICD C7B8 - Other secondary neuroendocrine tumors | $404,210 | ||||
| Total Medicare payment per Day at DRG | $1,394 | ||||
| Total Medicare payment per Day with ICD C7B8 - Other secondary neuroendocrine tumors | $1,418 | ||||
| Total Medicare payment per Hospitalization at DRG | $4,381 | ||||
| Total Medicare payment per Hospitalization with ICD C7B8 - Other secondary neuroendocrine tumors | $4,929 | ||||
| Total Medicare Charges at DRG | $13,619,287,561 | ||||
| Total Medicare Charges with ICD C7B8 - Other secondary neuroendocrine tumors | $2,426,971 | ||||
| Avg Charges at DRG | $26,051 | ||||
| Avg Charges with ICD C7B8 - Other secondary neuroendocrine tumors | $29,597 | ||||
| Mortality Rate at DRG | 0.18 | ||||
| Mortality Rate with ICD C7B8 - Other secondary neuroendocrine tumors | NA | ||||
| SNF Discharge Rate at DRG | 8.57 | ||||
| SNF Discharge Rate with ICD C7B8 - Other secondary neuroendocrine tumors | NA | ||||
| Home Discharge Rate at DRG | 72.49 | ||||
| Home Discharge Rate with ICD C7B8 - Other secondary neuroendocrine tumors | 73.17 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 142 |
| MAYO CLINIC HOSPITAL - SAINT MARYS CAMPUS | 1216 2ND ST SW | ROCHESTER | MN | 55902 | 98 |
| MOFFITT CANCER CENTER | 12902 MAGNOLIA DR | TAMPA | FL | 33612 | 86 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. JAMES R HOWE | 200 HAWKINS DR | IOWA CITY | IA | 52242 | 18 |
| Dr. RODNEY FRANCIS POMMIER | 3181 SW SAM JACKSON PARK RD | PORTLAND | OR | 97239 | 15 |
| Dr. JEFFREY A NORTON | 300 PASTEUR DR | STANFORD | CA | 94305 | 12 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. JAMES R HOWE | 200 HAWKINS DR | IOWA CITY | IA | 52242 | 20 |
| Dr. RODNEY FRANCIS POMMIER | 3181 SW SAM JACKSON PARK RD | PORTLAND | OR | 97239 | 17 |
| Dr. ERIC KAORU NAKAKURA | 1600 DIVISADERO ST | SAN FRANCISCO | CA | 94115 | 15 |